Home / 6990.HK : HKSE

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does 6990.HK make money? Does 6990.HK have pricing power? What's the Earnings Whisper? Will 6990.HK profit more as the business scales? What is 6990.HK's management track record? Is 6990.HK's current price justified?

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

HKD 424.80 +$24.20 (+6.04%)

HKSE · 30 Oct 2026 08:08 UTC

Previous Close

HKD 437.80

Day Range

HKD 422.40HKD 451.00

Year Range

HKD 339.60HKD 562.50

Market Cap

101.54B

AVG Volume

875.03K

Trailing/Forward PE

653.31/146.56

PEG ratio

-5.73

Dividend Yield

Next Earnings Date

2027-03-29

Primary Exchange

Hong Kong Stock Exchange

Revenue (CNY) · A

6990.HK Revenue (CNY) by year
Period	Revenue (CNY)
2025	2.25B
2024	2.09B
2023	1.7B
2022	927.99M

Net Income (CNY) · A

6990.HK Net Income (CNY) by year
Period	Net Income (CNY)
2025	-418.48M
2024	-291.74M
2023	-624.46M
2022	-711.72M

Operating Income (CNY) · A

6990.HK Operating Income (CNY) by year
Period	Operating Income (CNY)
2025	-368.17M
2024	-153.43M
2023	-413.49M
2022	-482.64M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (CNY) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 29 Mar 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Earnings: 6990.HK

Video analysis: 6990.HK

News: 6990.HK

Similar companies